Ignite Creation Date:
2024-05-06 @ 6:58 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05848414
Status:
RECRUITING
Last Update Posted:
2024-01-30
First Post:
2023-03-28
Brief Title:
Short Term Outcomes in Hospitalized Patients With Liver Cirrhosis
Sponsor:
Assiut University
Organization:
Assiut University
Study Overview
Official Title:
Short Term Outcomes in Hospitalized Patients With Liver Cirrhosis
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will be conducted to assess the baseline characteristics and evaluate the 90-day mortality of patients admitted with liver cirrhosis Also the study will be done to identify the risk factors of 90-day mortality
Detailed Description:
Liver cirrhosis is the end spectrum of all chronic liver diseases characterized by advanced fibrosis scarring and formation of regenerative nodules leading to hepatic architectural distortion
Liver cirrhosis is a major cause of health burden worldwide According to the Global Burden of Disease study liver cirrhosis caused 12 of global disability-adjusted life years and 2 of all deaths worldwide in 2010 the 14th leading cause of mortality
The progress rate of compensated cirrhosis to decompensated cirrhosis is approximately 58 and once it progresses to decompensated cirrhosis its mortality rate within 5 years becomes 85 without liver transplantation Since the progression of cirrhosis is accelerated each time a complication recurs the management and treatment of the complication are critical in enhancing the quality of life and the life expectancy of patients
Post-discharge outcomes are an integral component of healthcare as they may aid in determining the success and longevity of treatment and how clinicians approach future cases
This study will focus on the short-term outcomes of patients hospitalized with liver cirrhosis to provide insight into methods for future healthcare interventions
Liver cirrhosis is a major cause of health burden worldwide According to the Global Burden of Disease study liver cirrhosis caused 12 of global disability-adjusted life years and 2 of all deaths worldwide in 2010 the 14th leading cause of mortality
The progress rate of compensated cirrhosis to decompensated cirrhosis is approximately 58 and once it progresses to decompensated cirrhosis its mortality rate within 5 years becomes 85 without liver transplantation Since the progression of cirrhosis is accelerated each time a complication recurs the management and treatment of the complication are critical in enhancing the quality of life and the life expectancy of patients
Post-discharge outcomes are an integral component of healthcare as they may aid in determining the success and longevity of treatment and how clinicians approach future cases
This study will focus on the short-term outcomes of patients hospitalized with liver cirrhosis to provide insight into methods for future healthcare interventions
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None